Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 662
1.
Biomolecules ; 13(6)2023 06 15.
Article En | MEDLINE | ID: mdl-37371573

BACKGROUND: The carnitine/acylcarnitine carrier (CAC) represents the route of delivering acyl moieties to the mitochondrial matrix for accomplishing the fatty acid ß-oxidation. The CAC has a couple of Cys residues (C136 and C155) most reactive toward ROS and redox signaling compounds such as GSH, NO, and H2S. Among physiological compounds reacting with Cys, itaconate is produced during inflammation and represents the connection between oxidative metabolism and immune responses. The possible interaction between the CAC and itaconate has been investigated. METHODS: the modulatory effects of itaconate on the transport activity of the native and recombinant CAC were tested using the proteoliposome experimental model together with site-directed mutagenesis and computational analysis. RESULTS: Itaconate reacts with the CAC causing irreversible inhibition. Dose-response experiment performed with the native and recombinant protein showed IC50 for itaconate of 11 ± 4.6 mM and 8.4 ± 2.9 mM, respectively. The IC50 decreased to 3.8 ± 1.0 mM by lowering the pH from pH 7.0 to pH 6.5. Inhibition kinetics revealed a non-competitive type of inhibition. C136 is the main target of itaconate, as demonstrated by the increased IC50 of mutants in which this Cys was substituted by Val. The central role of C136 was confirmed by covalent docking. Administration of dimethyl itaconate to HeLa cells inhibited the CAC transport activity, suggesting that itaconate could react with the CAC also in intact cells.


Membrane Transport Proteins , Mitochondria , Humans , Carnitine/metabolism , Cysteine/metabolism , HeLa Cells/drug effects , Membrane Transport Proteins/drug effects , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Membrane Transport Modulators/pharmacology
2.
Future Med Chem ; 14(13): 991-1003, 2022 07.
Article En | MEDLINE | ID: mdl-35638444

Aim: To separate and evaluate 9-cyclopropylmethoxy-dihydrotetrabenazine (13a) and its stereoisomers for their high affinity for vesicular monoamine transporter-2 (VMAT2). Method: Stereoisomers of 13a were separated and configurations were ascertained by chiral chromatography and crystal diffraction combined with 1H-1H NOESY assay. Possible binding modes of eight stereoisomers and VMAT2 were explored by molecular docking assays. The VMAT2 affinity of the stereoisomers, inhibition in vivo and pharmacokinetics in rats were evaluated. Results: Three stereoisomers were obtained: P1, P2 and P3, and all had similar VMAT2 binding modes. P2 [(2R, 3R, 11bR)-13a] showed the highest potential VMAT2 binding activity (Ki = 0.75 nM), decreased locomotor activity in rats and had an oral absolute bioavailability of 92.0%. Conclusion: P2 has good efficacy and pharmacokinetic properties and warrants further development to treat tardive dyskinesia.


Membrane Transport Modulators/pharmacology , Tetrabenazine , Vesicular Monoamine Transport Proteins , Animals , Molecular Docking Simulation , Rats , Stereoisomerism , Tetrabenazine/analogs & derivatives , Tetrabenazine/chemistry , Tetrabenazine/pharmacology , Vesicular Monoamine Transport Proteins/metabolism
3.
Biochim Biophys Acta Mol Cell Res ; 1869(1): 119146, 2022 01.
Article En | MEDLINE | ID: mdl-34599984

Gaba-ergic neurons are a diverse cell class with extensive influence over cortical processing, but their role in experience-dependent plasticity is not completely understood. Here we addressed the role of cortical somatostatin- (SOM-INs) and vasoactive intestinal polypeptide- (VIP-INs) containing interneurons in a Pavlovian conditioning where stimulation of the vibrissae is used as a conditioned stimulus and tail shock as unconditioned one. This procedure induces a plastic change observed as an enlargement of the cortical functional representation of vibrissae activated during conditioning. Using layer-targeted, cell-selective DREADD transductions, we examined the involvement of SOM-INs and VIP-INs activity in learning-related plastic changes. Under optical recordings, we injected DREADD-expressing vectors into layer IV (L4) barrels or layer II/III (L2/3) areas corresponding to the activated vibrissae. The activity of the interneurons was modulated during all conditioning sessions, and functional 2-deoxyglucose (2DG) maps were obtained 24 h after the last session. In mice with L4 but not L2/3 SOM-INs suppressed during conditioning, the plastic change of whisker representation was absent. The behavioral effect of conditioning was disturbed. Both L4 SOM-INs excitation and L2/3 VIP-INs inhibition during conditioning did not affect the plasticity or the conditioned response. We found the activity of L4 SOM-INs is indispensable in the formation of learning-induced plastic change. We propose that L4 SOM-INs may provide disinhibition by blocking L4 parvalbumin interneurons, allowing a flow of information into upper cortical layers during learning.


Interneurons/physiology , Learning , Neural Inhibition , Neuronal Plasticity , Somatosensory Cortex/physiology , Animals , GABAergic Neurons/drug effects , GABAergic Neurons/metabolism , GABAergic Neurons/physiology , Interneurons/drug effects , Interneurons/metabolism , Membrane Transport Modulators/pharmacology , Mice , Somatosensory Cortex/cytology , Somatostatin/genetics , Somatostatin/metabolism , Vibrissae/innervation , Vibrissae/physiology
4.
Clin Pharmacol Ther ; 111(2): 404-415, 2022 02.
Article En | MEDLINE | ID: mdl-34605015

Quantitative prediction of drug-drug interactions (DDIs) involving organic anion transporting polypeptide (OATP)1B1/1B3 inhibition is limited by uncertainty in the translatability of experimentally determined in vitro inhibition potency (half-maximal inhibitory concentration (IC50 )). This study used an OATP1B endogenous biomarker-informed physiologically-based pharmacokinetic (PBPK) modeling approach to predict the effect of inhibitor drugs on the pharmacokinetics (PKs) of OATP1B substrates. Initial static analysis with about 42 inhibitor drugs, using in vitro IC50 values and unbound liver inlet concentrations (Iin,max,u ), suggested in vivo OATP1B inhibition risk for drugs with R-value (1+ Iin,max,u /IC50 ) above 1.5. A full-PBPK model accounting for transporter-mediated hepatic disposition was developed for coproporphyrin I (CP-I), an endogenous OATP1B biomarker. For several inhibitors (cyclosporine, diltiazem, fenebrutinib, GDC-0810, itraconazole, probenecid, and rifampicin at 3 different doses), PBPK models were developed and verified against available CP-I plasma exposure data to obtain in vivo OATP1B inhibition potency-which tend to be lower than the experimentally measured in vitro IC50 by about 2-fold (probenecid and rifampicin) to 37-fold (GDC-0810). Models verified with CP-I data are subsequently used to predict DDIs with OATP1B probe drugs, rosuvastatin and pitavastatin. The predicted and observed area under the plasma concentration-time curve ratios are within 20% error in 55% cases, and within 30% error in 89% cases. Collectively, this comprehensive study illustrates the adequacy and utility of endogenous biomarker-informed PBPK modeling in mechanistic understanding and quantitative predictions of OATP1B-mediated DDIs in drug development.


Atorvastatin/pharmacokinetics , Coproporphyrins/blood , Liver-Specific Organic Anion Transporter 1/antagonists & inhibitors , Liver/drug effects , Membrane Transport Modulators/pharmacology , Models, Biological , Rosuvastatin Calcium/pharmacokinetics , Biomarkers/blood , Computer Simulation , Drug Interactions , HEK293 Cells , Humans , Liver/metabolism , Liver-Specific Organic Anion Transporter 1/genetics , Liver-Specific Organic Anion Transporter 1/metabolism , Risk Assessment , Risk Factors
5.
J Med Chem ; 65(1): 303-322, 2022 01 13.
Article En | MEDLINE | ID: mdl-34962403

A series of modified N-cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine (CyPPA) analogues were synthesized by replacing the cyclohexane moiety with different 4-substituted cyclohexane rings, tyrosine analogues, or mono- and dihalophenyl rings and were subsequently studied for their potentiation of KCa2 channel activity. Among the N-benzene-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine derivatives, halogen decoration at positions 2 and 5 of benzene-substituted 4-pyrimidineamine in compound 2q conferred a ∼10-fold higher potency, while halogen substitution at positions 3 and 4 of benzene-substituted 4-pyrimidineamine in compound 2o conferred a ∼7-fold higher potency on potentiating KCa2.2a channels, compared to that of the parent template CyPPA. Both compounds retained the KCa2.2a/KCa2.3 subtype selectivity. Based on the initial evaluation, compounds 2o and 2q were selected for testing in an electrophysiological model of spinocerebellar ataxia type 2 (SCA2). Both compounds were able to normalize the abnormal firing of Purkinje cells in cerebellar slices from SCA2 mice, suggesting the potential therapeutic usefulness of these compounds for treating symptoms of ataxia.


Cerebellum , Membrane Transport Modulators , Potassium Channels, Calcium-Activated , Purkinje Cells , Pyrimidines , Spinocerebellar Ataxias , Animals , Female , Male , Mice , Cerebellum/drug effects , Disease Models, Animal , Ion Channel Gating , Membrane Transport Modulators/chemistry , Membrane Transport Modulators/pharmacology , Potassium Channels, Calcium-Activated/agonists , Potassium Channels, Calcium-Activated/metabolism , Purkinje Cells/drug effects , Pyrimidines/chemistry , Spinocerebellar Ataxias/drug therapy , Spinocerebellar Ataxias/metabolism , Spinocerebellar Ataxias/pathology , Structure-Activity Relationship
6.
ScientificWorldJournal ; 2021: 5381993, 2021.
Article En | MEDLINE | ID: mdl-34720766

Microbial infections remain a public health problem due to the upsurge of bacterial resistance. In this study, the antibacterial, antibiofilm, and efflux pump inhibitory activities of the stem bark of Acacia macrostachya, an indigenous African medicinal plant, were investigated. In traditional medicine, the plant is used in the treatment of microbial infections and inflammatory conditions. A crude methanol extract obtained by Soxhlet extraction was partitioned by column chromatography to obtain the petroleum ether, ethyl acetate, and methanol fractions. Antibacterial, efflux pump inhibition and antibiofilm formation activities were assessed by the high-throughput spot culture growth inhibition (HT-SPOTi), ethidium bromide accumulation, and the crystal violet retention assay, respectively. The minimum inhibitory concentrations (MICs) of the crude extract and major fractions ranged from 250 to ≥500 µg/mL. At a concentration of 3.9-250 µg/mL, all extracts demonstrated >80% inhibition of biofilm formation in S. aureus. In P. aeruginosa, the EtOAc fraction showed the highest antibiofilm activity (59-69%) while the pet-ether fraction was most active against E. coli biofilms (45-67%). Among the test samples, the crude extract, methanol, and ethyl acetate fractions showed remarkable efflux pump inhibition in S. aureus, E. coli, and P. aeruginosa. At ½ MIC, the methanol fraction demonstrated significant accumulation of EtBr in E. coli having superior efflux inhibition over the standard EPIs: chlorpromazine and verapamil. Tannins, flavonoids, triterpenoids, phytosterols, coumarins, and saponins were identified in preliminary phytochemical studies. Stigmasterol was identified in the EtOAc fraction. This study justifies the use of A. macrostachya in the treatment of infections in traditional medicine and highlights its potential as a source of bioactive compounds that could possibly interact with some resistance mechanisms in bacteria to combat antimicrobial resistance.


Acacia , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Plant Bark , Plant Extracts/pharmacology , Plant Stems , Anti-Bacterial Agents/isolation & purification , Biofilms/growth & development , Escherichia coli/drug effects , Escherichia coli/physiology , Humans , Membrane Transport Modulators/isolation & purification , Membrane Transport Modulators/pharmacology , Microbial Sensitivity Tests/methods , Plant Extracts/isolation & purification , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology
7.
Eur J Pharmacol ; 912: 174553, 2021 Dec 05.
Article En | MEDLINE | ID: mdl-34627805

Transient receptor potential ankyrin 1 (TRPA1) channel is a calcium permeable, non-selective cation channel, expressed in the sensory neurons and non-neuronal cells of different tissues. Initially studied for its role in pain and inflammation, TRPA1 has now functionally involved in multiple other physiological functions. TRPA1 channel has been extensively studied for modulation by pungent compounds present in the spices and herbs. In the last decade, the role of TRPA1 agonism in body weight reduction, secretion of hunger and satiety hormones, insulin secretion and thermogenesis, has unveiled the potential of the TRPA1 channel to be used as a preventive target to tackle obesity and associated comorbidities including insulin resistance in type 2 diabetes. In this review, we summarized the recent findings of TRPA1 based dietary/non-dietary modulation for its role in obesity prevention and therapeutics.


Biological Products/pharmacology , Membrane Transport Modulators/pharmacology , Obesity/prevention & control , TRPA1 Cation Channel/agonists , TRPA1 Cation Channel/physiology , Animals , Humans , TRPA1 Cation Channel/chemistry
8.
Ann Clin Transl Neurol ; 8(11): 2205-2209, 2021 11.
Article En | MEDLINE | ID: mdl-34612610

Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycopenia causes a drug-resistant metabolic epilepsy due to energy deficiency. Standard treatment for Glut1 deficiency syndrome is the ketogenic diet that decreases the demand for brain glucose by supplying ketones as alternative fuel. Treatment options are limited if patients fail the ketogenic diet. We present a case of successful diazoxide use with continuous glucose monitoring in a patient with Glut1 deficiency syndrome who did not respond to the ketogenic diet.


Blood Glucose Self-Monitoring , Carbohydrate Metabolism, Inborn Errors/diagnosis , Carbohydrate Metabolism, Inborn Errors/drug therapy , Diazoxide/pharmacology , Membrane Transport Modulators/pharmacology , Monosaccharide Transport Proteins/deficiency , Seizures/drug therapy , Adolescent , Carbohydrate Metabolism, Inborn Errors/blood , Diazoxide/administration & dosage , Female , Humans , Monosaccharide Transport Proteins/blood , Seizures/etiology
9.
Am J Physiol Cell Physiol ; 321(6): C932-C946, 2021 12 01.
Article En | MEDLINE | ID: mdl-34644122

Chloride transport across cell membranes is broadly involved in epithelial fluid transport, cell volume and pH regulation, muscle contraction, membrane excitability, and organellar acidification. The human genome encodes at least 53 chloride-transporting proteins with expression in cell plasma or intracellular membranes, which include chloride channels, exchangers, and cotransporters, some having broad anion specificity. Loss-of-function mutations in chloride transporters cause a wide variety of human diseases, including cystic fibrosis, secretory diarrhea, kidney stones, salt-wasting nephropathy, myotonia, osteopetrosis, hearing loss, and goiter. Although impactful advances have been made in the past decade in drug treatment of cystic fibrosis using small molecule modulators of the defective cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, other chloride channels and solute carrier proteins (SLCs) represent relatively underexplored target classes for drug discovery. New opportunities have emerged for the development of chloride transport modulators as potential therapeutics for secretory diarrheas, constipation, dry eye disorders, kidney stones, polycystic kidney disease, hypertension, and osteoporosis. Approaches to chloride transport-targeted drug discovery are reviewed herein, with focus on chloride channel and exchanger classes in which recent preclinical advances have been made in the identification of small molecule modulators and in proof of concept testing in experimental animal models.


Antiporters/drug effects , Chloride Channels/drug effects , Chlorides/metabolism , Drug Design , Drug Discovery , Membrane Transport Modulators/pharmacology , Animals , Antiporters/genetics , Antiporters/metabolism , Chloride Channels/genetics , Chloride Channels/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/drug effects , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Humans , Ion Transport , Kinetics , Membrane Transport Modulators/chemistry , Mutation , Sulfate Transporters/drug effects , Sulfate Transporters/genetics , Sulfate Transporters/metabolism
10.
Heart Rhythm ; 18(12): 2177-2186, 2021 12.
Article En | MEDLINE | ID: mdl-34481984

BACKGROUND: Oliceridine is a biased ligand at the µ-opioid receptor recently approved for the treatment of acute pain. In a thorough QT study, corrected QT (QTc) prolongation displayed peaks at 2.5 and 60 minutes after a supratherapeutic dose. The mean plasma concentration peaked at 5 minutes, declining rapidly thereafter. OBJECTIVE: The purpose of this study was to examine the basis for the delayed effect of oliceridine to prolong the QTc interval. METHODS: Repolarization parameters and tissue accumulation of oliceridine were evaluated in rabbit left ventricular wedge preparations over a period of 5 hours. The effects of oliceridine on ion channel currents were evaluated in human embryonic kidney and Chinese hamster ovary cells. Quinidine was used as a control. RESULTS: Oliceridine and quinidine produced a progressive prolongation of the QTc interval and action potential duration over a period of 5 hours, paralleling slow progressive tissue uptake of the drugs. Oliceridine caused modest prolongation of these parameters, whereas quinidine produced a prominent prolongation of action potential duration and QTc interval as well as development of early afterdepolarization (after 2 hours), resulting in a high torsades de pointes score. The 50% inhibitory concentration values for the oliceridine inhibition of the rapidly activating delayed rectifier current (human ether a-go-go current) and late sodium channel current were 2.2 and 3.45 µM when assessed after traditional acute exposure but much lower after 3 hours of drug exposure. CONCLUSION: Our findings suggest that a gradual increase of intracellular access of drugs to the hERG channels as a result of their intracellular uptake and accumulation can significantly delay effects on repolarization, thus confounding the assessment of QT interval prolongation and arrhythmic risk when studied acutely. The multi-ion channel effects of oliceridine, late sodium channel current inhibition in particular, point to a low risk of devloping torsades de pointes.


Arrhythmias, Cardiac , ERG1 Potassium Channel/antagonists & inhibitors , Spiro Compounds/pharmacokinetics , Thiophenes/pharmacokinetics , Analgesics, Opioid/pharmacokinetics , Animals , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/metabolism , Arrhythmias, Cardiac/physiopathology , Arrhythmias, Cardiac/prevention & control , Cell Line , Cricetulus , Humans , Inhibitory Concentration 50 , Long QT Syndrome/chemically induced , Long QT Syndrome/metabolism , Long QT Syndrome/physiopathology , Membrane Transport Modulators/pharmacology , Quinidine/pharmacokinetics , Tissue Distribution , Voltage-Gated Sodium Channel Blockers/pharmacokinetics
11.
Toxicol Appl Pharmacol ; 429: 115704, 2021 10 15.
Article En | MEDLINE | ID: mdl-34474082

Organic anion-transporting polypeptide 2B1 (OATP2B1) is a multispecific transporter mediating the cellular uptake of steroids and numerous drugs. OATP2B1 is abundantly expressed in the intestine and is also present in various tumors. Increased steroid hormone uptake by OATP2B1 has been suggested to promote progression of hormone dependent tumors. 13α-estrones are effective inhibitors of endogenous estrogen formation and are potential candidates to inhibit proliferation of hormone dependent cancers. Recently, we have identified a variety of 13α/ß-estrone-based inhibitors of OATP2B1. However, the nature of this interaction, whether these inhibitors are potential transported substrates of OATP2B1 and hence may be enriched in OATP2B1-overexpressing cells, has not yet been investigated. In the current study we explored the antiproliferative effect of the most effective OATP2B1 inhibitor 13α/ß-estrones in control and OATP2B1-overexpressing A431 carcinoma cells. We found an increased antiproliferative effect of 3-O-benzyl 13α/ß-estrones in both mock transfected and OATP2B1-overexpressing cells. However, C-2 halogenated 13α-estrones had a selective OATP2B1-mediated cell growth inhibitory effect. In order to demonstrate that increased sensitization can be attributed to OATP2B1-mediated cellular uptake, tritium labeled 2-bromo-13α-estrone was synthesized for direct transport measurements. These experiments revealed increased accumulation of [3H]2-bromo-13α-estrone due to OATP2B1 function. Our results indicate that C-2 halogenated 13α-estrones are good candidates in the design of anti-cancer drugs targeting OATP2B1.


Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/drug therapy , Cell Proliferation/drug effects , Estrone/pharmacology , Membrane Transport Modulators/pharmacology , Organic Anion Transporters/antagonists & inhibitors , Skin Neoplasms/drug therapy , Antineoplastic Agents/metabolism , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Estrone/analogs & derivatives , Estrone/metabolism , Humans , Membrane Transport Modulators/metabolism , Organic Anion Transporters/genetics , Organic Anion Transporters/metabolism , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
12.
Proc Natl Acad Sci U S A ; 118(28)2021 07 13.
Article En | MEDLINE | ID: mdl-34260402

Sinoatrial node myocytes (SAMs) act as cardiac pacemaker cells by firing spontaneous action potentials (APs) that initiate each heartbeat. The funny current (If) is critical for the generation of these spontaneous APs; however, its precise role during the pacemaking cycle remains unresolved. Here, we used the AP-clamp technique to quantify If during the cardiac cycle in mouse SAMs. We found that If is persistently active throughout the sinoatrial AP, with surprisingly little voltage-dependent gating. As a consequence, it carries both inward and outward current around its reversal potential of -30 mV. Despite operating at only 2 to 5% of its maximal conductance, If carries a substantial fraction of both depolarizing and repolarizing net charge movement during the firing cycle. We also show that ß-adrenergic receptor stimulation increases the percentage of net depolarizing charge moved by If, consistent with a contribution of If to the fight-or-flight increase in heart rate. These properties were confirmed by heterologously expressed HCN4 channels and by mathematical models of If Modeling further suggested that the slow rates of activation and deactivation of the HCN4 isoform underlie the persistent activity of If during the sinoatrial AP. These results establish a new conceptual framework for the role of If in pacemaking, in which it operates at a very small fraction of maximal activation but nevertheless drives membrane potential oscillations in SAMs by providing substantial driving force in both inward and outward directions.


Biological Clocks/physiology , Electrophysiological Phenomena , Myocytes, Cardiac/physiology , Sinoatrial Node/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Biological Clocks/drug effects , Computer Simulation , Diastole/drug effects , Diastole/physiology , Electrophysiological Phenomena/drug effects , HEK293 Cells , Humans , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/metabolism , Ivabradine/pharmacology , Membrane Transport Modulators/pharmacology , Mice, Inbred C57BL , Myocytes, Cardiac/drug effects , Sinoatrial Node/drug effects
13.
Am J Physiol Gastrointest Liver Physiol ; 321(2): G185-G199, 2021 08 01.
Article En | MEDLINE | ID: mdl-34132108

Recent studies in our lab have shown that the KV7 channel activator, flupirtine, inhibits colonic epithelial Cl- secretion through effects on submucosal neurons of the enteric nervous system (ENS). We hypothesized that flupirtine would also stimulate Na+ absorption as a result of reduced secretory ENS input to the epithelium. To test this hypothesis, unidirectional 22Na+ fluxes were measured under voltage-clamped conditions. Pharmacological approaches using an Ussing-style recording chamber combined with immunofluorescence microscopy techniques were used to determine the effect of flupirtine on active Na+ transport in the rat colon. Flupirtine stimulated electroneutral Na+ absorption in partially seromuscular-stripped colonic tissues, while simultaneously inhibiting short-circuit current (ISC; i.e., Cl- secretion). Both of these effects were attenuated by pretreatment with the ENS inhibitor, tetrodotoxin. The Na+/H+ exchanger isoform 3 (NHE-3)-selective inhibitor, S3226, significantly inhibited flupirtine-stimulated Na+ absorption, whereas the NHE-2-selective inhibitor HOE-694 did not. NHE-3 localization near the apical membranes of surface epithelial cells was also more apparent in flupirtine-treated colon versus control. Flupirtine did not alter epithelial Na+ channel (ENaC)-mediated Na+ absorption in distal colonic tissues obtained from hyperaldosteronaemic rats and had no effect in the normal ileum but did stimulate Na+ absorption in the proximal colon. Finally, the parallel effects of flupirtine on ISC (Cl- secretion) and Na+ absorption were significantly correlated with each other. Together, these data indicate that flupirtine stimulates NHE-3-dependent Na+ absorption, likely as a result of reduced stimulatory input to the colonic epithelium by submucosal ENS neurons.NEW & NOTEWORTHY We present a novel mechanism regarding regulation of epithelial ion transport by enteric neurons. Activation of neuronal KV7 K+ channels markedly stimulates Na+ absorption and inhibits Cl- secretion across the colonic epithelium. This may be useful in developing new treatments for diarrheal disorders, such as irritable bowel syndrome with diarrhea (IBS-D).


Aminopyridines/pharmacology , Colon/metabolism , Enteric Nervous System/metabolism , Intestinal Absorption , Sodium/metabolism , Animals , Colon/drug effects , Epithelial Sodium Channels/metabolism , Guanidines/pharmacology , Male , Membrane Transport Modulators/pharmacology , Methacrylates/pharmacology , Rats , Rats, Sprague-Dawley , Sodium-Hydrogen Exchangers/antagonists & inhibitors , Sodium-Hydrogen Exchangers/metabolism , Sulfones/pharmacology
14.
Cell Physiol Biochem ; 55(S3): 108-130, 2021 May 28.
Article En | MEDLINE | ID: mdl-34043299

Transient receptor potential vanilloid (TRPV) channels are part of the TRP channel superfamily and named after the first identified member TRPV1, that is sensitive to the vanillylamide capsaicin. Their overall structure is similar to the structure of voltage gated potassium channels (Kv) built up as homotetramers from subunits with six transmembrane helices (S1-S6). Six TRPV channel subtypes (TRPV1-6) are known, that can be subdivided into the thermoTRPV (TRPV1-4) and the Ca2+-selective TRPV channels (TRPV5, TRPV6). Contrary to Kv channels, TRPV channels are not primary voltage gated. All six channels have distinct properties and react to several endogenous ligands as well as different gating stimuli such as heat, pH, mechanical stress, or osmotic changes. Their physiological functions are highly diverse and subtype as well as tissue specific. In many tissues they serve as sensors for different pain stimuli (heat, pressure, pH) and contribute to the homeostasis of electrolytes, the maintenance of barrier functions and the development of macrophages. Due to their fundamental role in manifold physiological and pathophysiological processes, TRPV channels are promising targets for drug development. However, drugs targeting specific TRPV channels, that are suitable for drug therapy, are rare. Moreover, selective and potent compounds for further research at TRPV channels are often lacking. In this review different aspects of the structure, the different gating stimuli, the expression pattern, the physiological and pathophysiological roles as well as the modulating mechanisms of synthetic, natural and endogenous ligands are summarized.


Analgesics/pharmacology , Antineoplastic Agents/pharmacology , Immunologic Factors/pharmacology , Membrane Transport Modulators/pharmacology , TRPV Cation Channels/metabolism , Analgesics/chemistry , Analgesics/classification , Antineoplastic Agents/chemistry , Antineoplastic Agents/classification , Binding Sites , Brain/cytology , Brain/drug effects , Brain/metabolism , Humans , Immunologic Factors/chemistry , Immunologic Factors/classification , Ion Channel Gating/drug effects , Ligands , Lung/cytology , Lung/drug effects , Lung/metabolism , Membrane Transport Modulators/chemistry , Membrane Transport Modulators/classification , Models, Molecular , Organ Specificity , Protein Binding , Protein Isoforms/agonists , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/classification , Protein Isoforms/metabolism , Protein Structure, Secondary , Spleen/cytology , Spleen/drug effects , Spleen/metabolism , TRPV Cation Channels/agonists , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/classification
15.
Cell Physiol Biochem ; 55(S3): 145-156, 2021 May 28.
Article En | MEDLINE | ID: mdl-34043301

The population of regulatory T cells (Tregs) is critical for immunological self-tolerance and homeostasis. Proper ion regulation contributes to Treg lineage identity, regulation, and effector function. Identified ion channels include Ca2+ release-activated Ca2+, transient receptor potential, P2X, volume-regulated anion and K+ channels Kv1.3 and KCa3.1. Ion channel modulation represents a promising therapeutic approach for the treatment of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. This review summarizes studies with gene-targeted mice and pharmacological modulators affecting Treg number and function. Furthermore, participation of ion channels is illustrated and the power of future research possibilities is discussed.


Arthritis, Rheumatoid/drug therapy , Calcium/metabolism , Gene Expression Regulation/drug effects , Membrane Transport Modulators/pharmacology , Multiple Sclerosis/drug therapy , T-Lymphocytes, Regulatory/drug effects , Animals , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , Calcium/immunology , Calcium Release Activated Calcium Channels/genetics , Calcium Release Activated Calcium Channels/immunology , Calcium Signaling , Disease Models, Animal , Gene Expression Regulation/immunology , Humans , Intermediate-Conductance Calcium-Activated Potassium Channels/genetics , Intermediate-Conductance Calcium-Activated Potassium Channels/immunology , Kv1.3 Potassium Channel/genetics , Kv1.3 Potassium Channel/immunology , Membrane Proteins/genetics , Membrane Proteins/immunology , Membrane Transport Modulators/chemistry , Mice , Multiple Sclerosis/genetics , Multiple Sclerosis/immunology , Multiple Sclerosis/metabolism , Receptors, Purinergic P2X/genetics , Receptors, Purinergic P2X/immunology , Receptors, Purinergic P2X7/genetics , Receptors, Purinergic P2X7/immunology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology , Transient Receptor Potential Channels/genetics , Transient Receptor Potential Channels/immunology
16.
Commun Biol ; 4(1): 293, 2021 03 05.
Article En | MEDLINE | ID: mdl-33674682

Monoterpenes are major constituents of plant-derived essential oils and have long been widely used for therapeutic and cosmetic applications. The monoterpenes menthol and camphor are agonists or antagonists for several TRP channels such as TRPM8, TRPV1, TRPV3 and TRPA1. However, which regions within TRPV1 and TRPV3 confer sensitivity to monoterpenes or other synthesized chemicals such as 2-APB are unclear. In this study we identified conserved arginine and glycine residues in the linker between S4 and S5 that are related to the action of these chemicals and validated these findings in molecular dynamics simulations. The involvement of these amino acids differed between TRPV3 and TRPV1 for chemical-induced and heat-evoked activation. These findings provide the basis for characterization of physiological function and biophysical properties of ion channels.


Membrane Transport Modulators/pharmacology , Monoterpenes/pharmacology , Transient Receptor Potential Channels/drug effects , Amino Acid Sequence , Animals , Arginine , Camphor/chemistry , Camphor/pharmacology , Glycine , HEK293 Cells , Humans , Membrane Potentials , Membrane Transport Modulators/chemistry , Menthol/chemistry , Menthol/pharmacology , Mice , Molecular Dynamics Simulation , Molecular Structure , Monoterpenes/chemistry , Rats , Structure-Activity Relationship , Transient Receptor Potential Channels/genetics , Transient Receptor Potential Channels/metabolism
17.
Cell Physiol Biochem ; 55(S3): 87-107, 2021 Mar 06.
Article En | MEDLINE | ID: mdl-33667333

Potassium channels of the tandem of two-pore-domain (K2P) family were among the last potassium channels cloned. However, recent progress in understanding their physiological relevance and molecular pharmacology revealed their therapeutic potential and thus these channels evolved as major drug targets against a large variety of diseases. However, after the initial cloning of the fifteen family members there was a lack of potent and/or selective modulators. By now a large variety of K2P channel modulators (activators and blockers) have been described, especially for TASK-1, TASK-3, TREK-1, TREK2, TRAAK and TRESK channels. Recently obtained crystal structures of K2P channels, alanine scanning approaches to map drug binding sites, in silico experiments with molecular dynamics simulations (MDs) combined with electrophysiological studies to reveal the mechanism of channel inhibition/activation, yielded a good understanding of the molecular pharmacology of these channels. Besides summarizing drugs that were identified to modulate K2P channels, the main focus of this article is on describing the differential binding sites and mechanisms of channel modulation that are utilized by the different K2P channel blockers and activators.


Cardiac Conduction System Disease/drug therapy , Membrane Transport Modulators/pharmacology , Migraine Disorders/drug therapy , Potassium Channels, Tandem Pore Domain/metabolism , Potassium/metabolism , Action Potentials/drug effects , Action Potentials/physiology , Binding Sites , Cardiac Conduction System Disease/genetics , Cardiac Conduction System Disease/metabolism , Cardiac Conduction System Disease/pathology , Gene Expression , Humans , Ion Channel Gating/drug effects , Ion Transport , Ligands , Membrane Transport Modulators/chemistry , Membrane Transport Modulators/classification , Migraine Disorders/genetics , Migraine Disorders/metabolism , Migraine Disorders/pathology , Molecular Dynamics Simulation , Organ Specificity , Potassium Channels, Tandem Pore Domain/classification , Potassium Channels, Tandem Pore Domain/genetics , Protein Binding , Protein Isoforms/classification , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Secondary
18.
Cell Death Dis ; 12(3): 226, 2021 03 01.
Article En | MEDLINE | ID: mdl-33649312

Hypertrophic scar (HS) formation is a skin fibroproliferative disease that occurs following a cutaneous injury, leading to functional and cosmetic impairment. To date, few therapeutic treatments exhibit satisfactory outcomes. The mechanical force has been shown to be a key regulator of HS formation, but the underlying mechanism is not completely understood. The Piezo1 channel has been identified as a novel mechanically activated cation channel (MAC) and is reportedly capable of regulating force-mediated cellular biological behaviors. However, the mechanotransduction role of Piezo1 in HS formation has not been investigated. In this work, we found that Piezo1 was overexpressed in myofibroblasts of human and rat HS tissues. In vitro, cyclic mechanical stretch (CMS) increased Piezo1 expression and Piezo1-mediated calcium influx in human dermal fibroblasts (HDFs). In addition, Piezo1 activity promoted HDFs proliferation, motility, and differentiation in response to CMS. More importantly, intradermal injection of GsMTx4, a Piezo1-blocking peptide, protected rats from stretch-induced HS formation. Together, Piezo1 was shown to participate in HS formation and could be a novel target for the development of promising therapies for HS formation.


Calcium Signaling , Cicatrix, Hypertrophic/metabolism , Fibroblasts/metabolism , Ion Channels/metabolism , Mechanotransduction, Cellular , Membrane Proteins/metabolism , Skin/metabolism , Animals , Apoptosis , Calcium Signaling/drug effects , Case-Control Studies , Cell Differentiation , Cell Movement , Cell Proliferation , Cells, Cultured , Cicatrix, Hypertrophic/genetics , Cicatrix, Hypertrophic/pathology , Cicatrix, Hypertrophic/prevention & control , Disease Models, Animal , Fibroblasts/drug effects , Fibroblasts/pathology , Humans , Intercellular Signaling Peptides and Proteins/pharmacology , Ion Channels/antagonists & inhibitors , Ion Channels/genetics , Male , Mechanotransduction, Cellular/drug effects , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Membrane Transport Modulators/pharmacology , Rats, Sprague-Dawley , Skin/drug effects , Skin/pathology , Spider Venoms/pharmacology
19.
Cell Physiol Biochem ; 55(S3): 14-45, 2021 Mar 03.
Article En | MEDLINE | ID: mdl-33656309

Although ion channels are crucial in many physiological processes and constitute an important class of drug targets, much is still unclear about their function and possible malfunctions that lead to diseases. In recent years, computational methods have evolved into important and invaluable approaches for studying ion channels and their functions. This is mainly due to their demanding mechanism of action where a static picture of an ion channel structure is often insufficient to fully understand the underlying mechanism. Therefore, the use of computational methods is as important as chemical-biological based experimental methods for a better understanding of ion channels. This review provides an overview on a variety of computational methods and software specific to the field of ion-channels. Artificial intelligence (or more precisely machine learning) approaches are applied for the sequence-based prediction of ion channel family, or topology of the transmembrane region. In case sufficient data on ion channel modulators is available, these methods can also be applied for quantitative structureactivity relationship (QSAR) analysis. Molecular dynamics (MD) simulations combined with computational molecular design methods such as docking can be used for analysing the function of ion channels including ion conductance, different conformational states, binding sites and ligand interactions, and the influence of mutations on their function. In the absence of a three-dimensional protein structure, homology modelling can be applied to create a model of your ion channel structure of interest. Besides highlighting a wide range of successful applications, we will also provide a basic introduction to the most important computational methods and discuss best practices to get a rough idea of possible applications and risks.


Artificial Intelligence , Ion Channels/chemistry , Membrane Transport Modulators/chemistry , Molecular Dynamics Simulation , Software , Animals , Binding Sites , Humans , Ion Channel Gating/drug effects , Ion Channels/agonists , Ion Channels/antagonists & inhibitors , Ligands , Membrane Transport Modulators/pharmacology , Models, Molecular , Protein Binding , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand , Protein Interaction Domains and Motifs , Quantitative Structure-Activity Relationship , Structural Homology, Protein
20.
Protein J ; 40(2): 205-222, 2021 04.
Article En | MEDLINE | ID: mdl-33751342

Pollen tube elongation is characterized by a highly-polarized tip growth process dependent on an efficient vesicular transport system and largely mobilized by actin cytoskeleton. Pollen tubes are an ideal model system to study exocytosis, endocytosis, membrane recycling, and signaling network coordinating cellular processes, structural organization and vesicular trafficking activities required for tip growth. Proteomic analysis was applied to identify Nicotiana tabacum Differentially Abundant Proteins (DAPs) after in vitro pollen tube treatment with membrane trafficking inhibitors Brefeldin A, Ikarugamycin and Wortmannin. Among roughly 360 proteins separated in two-dimensional gel electrophoresis, a total of 40 spots visibly changing between treated and control samples were identified by MALDI-TOF MS and LC-ESI-MS/MS analysis. The identified proteins were classified according to biological processes, and most proteins were related to pollen tube energy metabolism, including ammino acid synthesis and lipid metabolism, structural features of pollen tube growth as well modification and actin cytoskeleton organization, stress response, and protein degradation. In-depth analysis of proteins corresponding to energy-related pathways revealed the male gametophyte to be a reliable model of energy reservoir and dynamics.


Membrane Transport Modulators/pharmacology , Pollen Tube , Proteome , Brefeldin A/pharmacology , Lactams/pharmacology , Plant Proteins/analysis , Plant Proteins/chemistry , Plant Proteins/metabolism , Pollen Tube/chemistry , Pollen Tube/drug effects , Pollen Tube/growth & development , Pollen Tube/metabolism , Proteome/analysis , Proteome/chemistry , Proteome/drug effects , Proteome/metabolism , Nicotiana/metabolism , Wortmannin/pharmacology
...